Table 6 Success rate, 3 and 6 months following thoracoscopic talc pleurodesis.

Non small cell lung cancer

136/166

[81.9]

130/166

[78.3]

Breast cancer

94/97

[96.9]

91/97

[93.8]

Ovarian cancer

22/24

[91.6]

22/24

[91.6]

Uterine cancer

13/16

[81.2]

12/16

[75.0]

Colon cancer

13/16

[81.2]

12/16

[75.0]

Sarcoma

11/14

[78.5]

10/14

[71.4]

Gastric cancer

10/13

[76.9]

10/13

[76.9]

Lymphoma

11/13

[84.6]

11/13

[84.6]

Small cell lung cancer

8/10

[80.0]

8/10

[80.0]

Pleural mesothelioma

8/10

[80.0]

8/10

[80.0]

Melanoma

5/7

[71.4]

5/7

[71.4]

Oesophageal cancer

2/4

[50.0]

2/4

[50.0]

Testicular cancer

3/4

[75.0]

3/4

[75.0]

Hepatocellular cancer

2/3

[66.6]

2/3

[66.6]

Parotid gland cancer

1/2

[50.0]

1/2

[50.0]

Gallbladder cancer

1/1

[100.0]

Death with no recurrence